Revvity Execs to Present at Three Major Healthcare Conferences in September
Event summary
- Revvity will present at three investor conferences in September 2026: Wells Fargo, Morgan Stanley, and Baird’s Global Healthcare Conference.
- CEO Prahlad Singh will speak at the Wells Fargo conference on September 9, 2026.
- CFO Max Krakowiak will present at the Morgan Stanley conference on September 14, 2026.
- Steve Willoughby, SVP of Investor Relations, will speak at Baird’s conference on September 15, 2026.
The big picture
Revvity’s participation in three major healthcare investor conferences underscores its push to engage with key stakeholders amid a rapidly evolving diagnostics and biotech landscape. As a $2.9 billion revenue company, its strategic priorities—particularly in multi-omics and biomarker identification—will be closely watched by investors assessing its ability to maintain growth momentum.
What we're watching
- Strategic Messaging
- How Revvity’s presentations will emphasize its focus areas in translational multi-omics, biomarker identification, and diagnostics.
- Market Positioning
- Whether the company can differentiate itself in a competitive healthcare solutions market with $2.9 billion in 2025 revenue.
- Investor Sentiment
- The impact of these conferences on investor confidence, particularly given Revvity’s inclusion in the S&P 500.
Related topics